Rating History for Jazz Pharmaceuticals (JAZZ) by Canaccord
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 7/16/2026 | Gary Newman | New Coverage | Buy (N/A) |
290.00 (N/A) |
239.32 (247.53) |
3.43% | Details |
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 7/16/2026 | Gary Newman | New Coverage | Buy (N/A) |
290.00 (N/A) |
239.32 (247.53) |
3.43% | Details |
![]() |
|||||||
![]() |
|||||||